Bayer, Novartis Settle MS Drug Dispute For $200M
After years of negotiations, drug makers Bayer AG and Novartis AG finally settled their dispute over multiple sclerosis drug Betaseron on Monday, agreeing to give Bayer full control of the product...To view the full article, register now.
Already a subscriber? Click here to view full article